Cited by 252DNA Repair MechanismsPARP inhibition in cancer therapyBRCA gene mutations in cancer

BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair

Open access
Bunting, Samuel F., Callén, Elsa, Kozak, Marina L., Kim, Jung Min, Wong, Nancy, López-Contreras, Andrés J., Ludwig, Thomas, Baer, Richard +6 more·2012·Molecular Cell

Abstract

Brca1 is required for DNA repair by homologous recombination (HR) and normal embryonic development. Here we report that deletion of the DNA damage response factor 53BP1 overcomes embryonic lethality in Brca1-nullizygous mice and rescues HR deficiency, as measured by hypersensitivity to polyADP-ribose polymerase (PARP) inhibition. However, Brca1,53BP1 double-deficient cells are hypersensitive to DNA interstrand crosslinks (ICLs), indicating that BRCA1 has an additional role in DNA crosslink repair that is distinct from HR. Disruption of the nonhomologous end-joining (NHEJ) factor, Ku, promotes DNA repair in Brca1-deficient cells; however deletion of either Ku or 53BP1 exacerbates genomic instability in cells lacking FANCD2, a mediator of the Fanconi anemia pathway for ICL repair. BRCA1 therefore has two separate roles in ICL repair that can be modulated by manipulating NHEJ, whereas FANCD2 provides a key activity that cannot be bypassed by ablation of 53BP1 or Ku.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2012.02.015

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bunting, S. F., Callén, E., Kozak, M. L., Kim, J. M., Wong, N., López-Contreras, A. J., Ludwig, T., Baer, R., Faryabi, R. B., Malhowski, A., Chen, H.-T., Fernandez-Capetillo, O., D'Andrea, A., & Nussenzweig, A.
Affiliations
  • National Institutes of Health (US)
  • Harvard University (US)
  • Columbia University Irving Medical Center (US)
Corresponding author
Nussenzweig, André
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2012-04
Volume
46
Issue
2
Pages
125-135
ISSN
1097-2765 (ISSN-L)
OpenAlex
W2047119008
Cited by
252
References
59
Citations by year
2026: 1 · 2025: 2 · 2024: 5 · 2023: 9 · 2022: 6 · 2021: 24 · 2020: 20 · 2019: 18 · 2018: 21 · 2017: 19 · 2016: 30 · 2015: 16 · 2014: 28 · 2013: 33 · 2012: 20
FWCI
12.46
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
Funders
  • National Institutes of Health (Z99 CA999999)
  • U.S. Bureau of Land Management
  • National Heart, Lung, and Blood Institute (R37HL052725)
  • National Cancer Institute (K99 CA160574, Y99 CA999999, Z01BC010283, 1K99CA160574-01, Z01BC010959)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043889)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Keywords
BRCA1, interstrand crosslink repair, homologous recombination, 53BP1, Ku, non-homologous end joining, FANCD2, Fanconi anemia pathway, genomic instability, embryonic lethality, DNA damage response
MeSH terms
Ku Autoantigen, Animals, DNA Repair, DNA-Binding Proteins, Sequence Deletion, BRCA1 Protein, Antigens, Nuclear, Genomic Instability, Mice, Fanconi Anemia Complementation Group D2 Protein, Gene Knockdown Techniques, Homologous Recombination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review